Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 Visningar
administrator
08/04/23
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
Visa mer
Facebook-kommentarer
Inga kommentarer hittades